BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 10124321)

  • 1. Bears circle Medical Care America.
    Lutz S
    Mod Healthc; 1993 Mar; 23(10):17. PubMed ID: 10124321
    [No Abstract]   [Full Text] [Related]  

  • 2. SEC adds to delay in Coram deal.
    Burns J
    Mod Healthc; 1994 May; 24(20):6. PubMed ID: 10133523
    [No Abstract]   [Full Text] [Related]  

  • 3. Abbey to pay $197 million for Total Pharmaceutical.
    Burns J
    Mod Healthc; 1993 Sep; 23(37):21. PubMed ID: 10128184
    [No Abstract]   [Full Text] [Related]  

  • 4. Medical Care feels safe from buyout.
    Burns J
    Mod Healthc; 1994 Mar; 24(10):49. PubMed ID: 10131932
    [No Abstract]   [Full Text] [Related]  

  • 5. Coram team may not last--analysts.
    Burns J
    Mod Healthc; 1994 Jul; 24(30):24. PubMed ID: 10135208
    [No Abstract]   [Full Text] [Related]  

  • 6. Critical Care America, Medical Care Int'l to merge.
    Lutz S
    Mod Healthc; 1992 Jun; 22(25):32. PubMed ID: 10118638
    [No Abstract]   [Full Text] [Related]  

  • 7. Shares of T2 Medical rise on buyout talk.
    Lutz S
    Mod Healthc; 1993 May; 23(22):10. PubMed ID: 10126259
    [No Abstract]   [Full Text] [Related]  

  • 8. Scrutiny from the states. Except for Columbia, probes having little effect on deals.
    Japsen B
    Mod Healthc; 1997 Feb; 27(8):53, 55. PubMed ID: 10164952
    [No Abstract]   [Full Text] [Related]  

  • 9. Inside events unraveled T2 buyout.
    Burns J
    Mod Healthc; 1994 May; 24(18):17-8, 20, 24. PubMed ID: 10133221
    [No Abstract]   [Full Text] [Related]  

  • 10. Cutting edge. Surgical company is poised for growth--or acquisition.
    Japsen B
    Mod Healthc; 1998 Apr; 28(17):34. PubMed ID: 10179160
    [No Abstract]   [Full Text] [Related]  

  • 11. T2 agrees to 4-way merger that will create 2nd-largest home infusion company.
    Burns J
    Mod Healthc; 1994 Feb; 24(7):32. PubMed ID: 10131772
    [No Abstract]   [Full Text] [Related]  

  • 12. How self-referrals can go sour. The travails of T2 and its doctor investors.
    Sternberg S
    Med Econ; 1994 Jun; 71(11):116-27. PubMed ID: 10134208
    [No Abstract]   [Full Text] [Related]  

  • 13. Healthcare stocks: some bright spots in a cloudy year.
    Nemes J
    Mod Healthc; 1993 Feb; 23(5):47. PubMed ID: 10123709
    [No Abstract]   [Full Text] [Related]  

  • 14. W.R. Grace set to become 3rd-largest home infusion provider in purchase deal.
    Burns J
    Mod Healthc; 1994 Mar; 24(11):20. PubMed ID: 10132304
    [No Abstract]   [Full Text] [Related]  

  • 15. MCI Critical Care merger approved.
    Lutz S
    Mod Healthc; 1992 Sep; 22(37):57. PubMed ID: 10120371
    [No Abstract]   [Full Text] [Related]  

  • 16. Medical Care sells Critical Care for $175 million.
    Burns J
    Mod Healthc; 1994 Jan; 24(4):6. PubMed ID: 10131155
    [No Abstract]   [Full Text] [Related]  

  • 17. Medical Care aims at controlled expansion.
    Lutz S
    Mod Healthc; 1987 Dec; 17(26):61. PubMed ID: 10285063
    [No Abstract]   [Full Text] [Related]  

  • 18. Healthcare LBO bid not your usual deal.
    Lutz S
    Mod Healthc; 1989 May; 19(18):60, 62. PubMed ID: 10293043
    [No Abstract]   [Full Text] [Related]  

  • 19. Homedco and Abbey among companies that have viewed T2's books.
    Burns J
    Mod Healthc; 1994 Jan; 24(5):10. PubMed ID: 10131365
    [No Abstract]   [Full Text] [Related]  

  • 20. When not-for-profits decide to make a buck.
    Findlay S
    Bus Health; 1996 Mar; 14(3):38-9, 41-2, 44-6. PubMed ID: 10156386
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.